SCHEMBL7982477

SCHEMBL7982477

COC(=O)c1ccc(N2CCN(C(=O)c3ccc[nH]3)CC2)c(C(F)(F)F)c1

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 5/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2C19 P33261 1/20 0.69
HPGDS O60760 1/20 0.54
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
NPY2R P49146 1/20 0.46
RBP4 P02753 2/20 0.45
NPC1 O15118 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971528 0.85 KMT2A (0.66) SLC9A1CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL7985451 0.83 ALDH1A1 (0.54) SLC9A1CYP3A4CYP2C19ALDH1A1KMT2A
Sabiporide SCHEMBL29385812 0.82 SLC9A1 (0.70) SLC9A1CYP3A4CYP2C19HPGDSNPY2R
Sabiporide SCHEMBL1286662 0.82 SLC9A1 (0.70) SLC9A1CYP3A4CYP2C19HPGDSNPY2R
SCHEMBL14491835 0.82 SLC9A1 (0.85) SLC9A1CYP3A4CYP2C19HPGDSNPY2R
Sabiporide SCHEMBL1286663 0.82 SLC9A1 (1.00) SLC9A1CYP3A4CYP2C19
Sabiporide SCHEMBL1286645 0.81 SLC9A1 (0.69) SLC9A1CYP3A4CYP2C19HPGDSNPY2R
SCHEMBL7985330 0.81 NPY2R (0.57) ALDH1A1KMT2ANPY2RRBP4
SCHEMBL7982517 0.81 RBP4 (0.54) SLC9A1CYP3A4CYP2C19ALDH1A1KMT2A
Sabiporide SCHEMBL27472449 0.81 SLC9A1 (0.89) SLC9A1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323207-B1 TREATMENT OR REDUCTION OF TISSUE DAMAGE DUE TO ISCHAEMIA WHICH COMPRISES ADMINISTERING TO A HOST SUFFERING FROM ISCHAEMIA BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-27 US disclosed